Submitted by Anonymous (not verified) on 29 July 2024 - 11:06
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 11, Status: Authorised